Teriparatide
Teriparatide (recombinant human parathyroid hormone) is a potent anabolic agent used in the treatment of osteoporosis. It is manufactured and marketed by Eli Lilly and Company.
| Trivial name | Teriparatide |
| Catalog Number | TP-054CL |
| Alternative Name(s) | Teriparatide |
| Research Area | Endocrine disorders |
| Molecular Formula | C181H291N55O51S2 |
| CAS# | 52232-67-4 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Teriparatide-22392.htm |
| Additional Information | For the treatment of osteoporosis in men and postmenopausal women who are at high risk for having a fracture. Also used to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture. |